Replies to post #85 on Skye Bioscience Inc (SKYE)

[Vinpat]

Those 14.8 million shares are part of the $5 million they just raised. It includes warrants that if exercised, will raise another $7.4 million on top of the $5 million. $12.4 million at 84 cents per share on average which is about where the stock is trading now and it gives them the cash to get into Phase 2. Not seeing the issue with it.

[botlow]

It is NOT another offering, simply registering the shares of the recent private placement, the shares underlying those warrants, and also the shares from previous offerings. The average price of the recent deal, if warrants were fully exercised, is just under $1.00. And look at a list of the names involved, they are all very high net worth or long term fundamental players. There are no arbitrage or short term types at all that will end up being supply in the market.